The Discounted Cash Flow (DCF) valuation of Aurobindo Pharma Ltd (AUROPHARMA.NS) is 592.60 INR. With the latest stock price at 1,147.80 INR, the upside of Aurobindo Pharma Ltd based on DCF is -48.4%.
Based on the latest price of 1,147.80 INR and our DCF valuation, Aurobindo Pharma Ltd (AUROPHARMA.NS) is a sell. selling AUROPHARMA.NS stocks now will result in a potential gain of 48.4%.
| Range | Selected | |
| WACC / Discount Rate | 12.7% - 15.1% | 13.9% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 499.56 - 733.80 | 592.60 |
| Upside | -56.5% - -36.1% | -48.4% |